Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial

被引:21
|
作者
Ozakbas, Serkan [1 ]
Turkoglu, Recai [2 ]
Tamam, Yusuf [3 ]
Terzi, Murat [4 ]
Taskapilioglu, Ozlem [5 ]
Yucesan, Canan [6 ]
Baser, Hatice Limoncu [1 ]
Gencer, Mehmet [2 ]
Akil, Esref [3 ]
Sen, Sedat [4 ]
Turan, Omer Faruk [5 ]
Sorgun, Mine Hayriye [6 ]
Yigit, Pinar [1 ]
Turkes, Nevin [5 ]
机构
[1] Dokuz Eylul Univ, Fac Med, Dept Neurol, Izmir, Turkey
[2] Haydarpasa Educ & Training Hosp, Istanbul, Turkey
[3] Dicle Univ, Diyarbakir, Turkey
[4] Ondokuz Mayis Univ, Samsun, Turkey
[5] Uludag Univ, Bursa, Turkey
[6] Ankara Univ, Ankara, Turkey
关键词
Multiple sclerosis; Cognition; Prognosis; Prevalence; BRIEF REPEATABLE BATTERY; QUALITY-OF-LIFE; FOLLOW-UP; DYSFUNCTION; POPULATION; DEPRESSION; DISABILITY; MS;
D O I
10.1016/j.msard.2018.03.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Cognitive impairment (CI) is a common problem in multiple sclerosis (MS), may occur either in early or late phase of the disease, and impairs quality of life. Objectives: This study aimed to determine the prevalence of CI and related risk factors in relapsing-remitting MS (RRMS) patients in Turkey. Methods: The present cross-sectional, multi-center, and nationally representative study included RRMS patients. Sociodemographic characteristics, cognitive functions and additional outcomes were compared between patients with and without CI. Results: The analyses included 487 RRMS patients. According to the BRB-N battery results, CI prevalence was 53.7%. There was a negative significant correlation of BRB-N subtests with age, disease duration, and EDSS and MSNQ-patient rated scores. On the logistic regression analysis, increased age, living in village/rural area, high income level, and high EDSS score were significant increasing risk factors in the development of CI. Conclusions: This is the first national cognitive data obtained from MS in Turkey, which is a country between Europe and Asia and thus has characteristics of both continents. The similarity of the results of the present study obtained from Turkey to the Western-based data indicates that CI is universal in MS and the main factors affecting CI have not changed.
引用
收藏
页码:70 / 76
页数:7
相关论文
共 50 条
  • [1] Cognitive impairment in patients with relapsing-remitting multiple sclerosis
    Mendes, M. F.
    Balsimelli, S.
    Tilbery, C. P.
    MULTIPLE SCLEROSIS, 2006, 12 : S142 - S142
  • [2] Cognitive impairment in relapsing-remitting multiple sclerosis patients
    Altinkaya, A.
    Ozcan, E.
    Yandim-Kuscu, D.
    Kurt, E.
    Bingol, A.
    Kirbas, D.
    Topcular, B.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 406 - 406
  • [3] Cognitive Impairment In Relapsing-Remitting Multiple Sclerosis
    Topcular, Baris
    Ozcan, M. Emin
    Kurt, Elif
    Kuscu, Demet Yandim
    Icen, Nilufer Kale
    Sutlas, Pakize Nevin
    Kirbas, Dursun
    Bingol, Ayhan
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2012, 49 (03): : 178 - 182
  • [4] Cognitive Impairment in Patients with Early Relapsing-Remitting Multiple Sclerosis
    Keklikoglu, Hava Doenmez
    Yoldas, Tahir Kurtulus
    Zengin, Oezkan
    Banu Solak, Elif
    Keskin, Selda
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2010, 47 (02): : 88 - 90
  • [5] Predicting cognitive impairment in relapsing-remitting multiple sclerosis
    Summers, M.
    Anderson, V. M.
    Fisniku, L.
    Davies, G. R.
    Rashid, W.
    Cipolotti, L.
    Ron, M. A.
    JOURNAL OF NEUROLOGY, 2006, 253 : 7 - 7
  • [6] Mild cognitive impairment in relapsing-remitting multiple sclerosis
    Georgia Deretzi
    Anastasia Varsamopoulou
    George Lagomatis-Lazopoulos
    George Floros
    Konstantinos Petsanis
    Evaggelos Papamihalis
    Aikaterini Dimakopoulou
    Nikolaos Grigoriadis
    Annals of General Psychiatry, 7 (Suppl 1)
  • [7] Frequency of cognitive impairment in relapsing-remitting multiple sclerosis patients in Turkey and affecting factors
    Ozakbas, S.
    Turkoglu, R.
    Tamam, Y.
    Terzi, M.
    Taskapilioglu, O.
    Yucesan, C.
    Limoncu, H.
    Gencer, M.
    Akil, E.
    Sen, S.
    Turan, O. F.
    Sorgun, M. H.
    Yigit, P.
    Turkes, N.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 458 - 459
  • [8] Cognitive impairment and cytokine profile in relapsing-remitting multiple sclerosis patients
    Petrov, A. M.
    Ivashkova, E. V.
    Ilves, A. G.
    Mineev, K. K.
    Reznikova, T. N.
    Stolyarov, I. D.
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2008, 69 (03) : 146 - 146
  • [9] The incidence of cognitive impairment among Hungarian relapsing-remitting multiple sclerosis patients
    Sandi, D.
    Biernacki, T.
    Fricska-Nagy, Z.
    Szekeres, D.
    Kincses, Z. T.
    Fuvesi, J.
    Rozsa, C.
    Kasa, K.
    Matolcsi, J.
    Zboznovits, D.
    Burany, Z.
    Langane, E.
    Vecsei, L.
    Bencsik, K.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 706 - 706
  • [10] Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome
    Sandi, D.
    Kasa, K.
    Biernacki, T.
    Szekeres, D.
    Zboznovits, D.
    Pyreschitz, A.
    Fuevesi, J.
    Kincses, Z. T.
    Rozsa, C.
    Matolcsi, J.
    Szerp, P.
    Langane, E.
    Vecsei, L.
    Bencsik, K.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 723 - 724